(Total Views: 457)
Posted On: 08/13/2019 8:40:28 AM
Post# of 83890
![Avatar](https://investorshangout.com/images/ProfileImages/726024511_36578_horse.jpg)
Re: breezerunner #12002
EuroMed Therapeutics is building the ninth Israeli licensed producer to capitalize on the domestic medical marijuana market and Europe’s nascent export market — worth upwards of $66 billion .
- Israeli Licensed Producer: EuroMed is building Israel’s ninth licensed producer, compared to more than 160 LPs across Canada.
- Low Cost Production: Israel has an ideal climate for year round outdoor cannabis production — significantly lowering costs.
- European End Markets: Israel’s strategic location makes it ideal for exporting to Europe, where consumers pay $18+ per gram.
- Access to Talent: Israel is a global leader in cannabis research, as well as a biotech and pharmaceutical hub.
https://euromedtherapeutics.com/
$$$$UNVC$$$$
- Israeli Licensed Producer: EuroMed is building Israel’s ninth licensed producer, compared to more than 160 LPs across Canada.
- Low Cost Production: Israel has an ideal climate for year round outdoor cannabis production — significantly lowering costs.
- European End Markets: Israel’s strategic location makes it ideal for exporting to Europe, where consumers pay $18+ per gram.
- Access to Talent: Israel is a global leader in cannabis research, as well as a biotech and pharmaceutical hub.
https://euromedtherapeutics.com/
$$$$UNVC$$$$
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
"An investment in knowledge pays the best interest."
Benjamin Franklin
All posts are my opinion only.
Benjamin Franklin
All posts are my opinion only.